Beryllium Bioavailability
Beryllium Bioavailability is the proportion of ingested or inhaled beryllium that is absorbed and becomes accessible for biological interaction within the body, distinguishing it from other measures of exposure by specifically quantifying the fraction that enters systemic circulation and can potentially induce toxicological effects.
14
Publications
376
Citations
43
Authors
30
Institutions
Publications per year
2017–2026
4
Parents
14
1–5 of 14
43
National Institute for Occupational Safety and Health, United States
2 publications · 77 citations
2
h-index
2
h-index
1
h-index
1
h-index
1
h-index
1–5 of 43
30
Mental Research Institute
Palo Alto, United States
2 h-index
6 publications
275 citations
ETH Zurich
Zurich, Switzerland
1 h-index
3 publications
69 citations
Federal Medical-Biological Agency
Moscow, Russia
1 h-index
2 publications
50 citations
Key Laboratory of Guangdong Province
Guangzhou, China
1 h-index
2 publications
60 citations

Centers for Disease Control and Prevention
Atlanta, United States
1 h-index
2 publications
56 citations
University of Newcastle Australia
Newcastle, Australia
1 h-index
5 publications
195 citations

Aberystwyth University
Aberystwyth, United Kingdom
1 h-index
1 publications
10 citations

Bhabha Atomic Research Centre
Mumbai, India
1 h-index
2 publications
26 citations
1–8 of 30
1 publications · 32 citations
1
h-index
1 publications · 23 citations
1
h-index
1 publications · 33 citations
1
h-index
1 publications · 39 citations
1
h-index
1 publications · 26 citations
1
h-index
1–5